ALNY
Alnylam Pharmaceuticals, Inc. β’ Healthcare (#8 of 11)
$278.09
-4.63 (-1.64%)
View:
Close:$278.09
Vol:EXTREME(95%ile)
Ratio:1.67x
|RSI:39(Neutral)
MACD:β
β₯75%25-75%<25%
Vol.%
Sector Rotation
2026-06-18(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRALβ²0 UpβΌ0 Down1 Hold
Jun 4HC Wainwright & Co.
βBuy
May 19Citigroup
βBuy
Price Targets
β²0 RaisesβΌ0 Lowers
Jun 4HC Wainwright & Co.
$510β$510New
May 19Citigroup
$380New
Trade Setup
ATR-basedEntry$278.09
Target$298.54 (+7.4%)
Stop$262.75
R/R1.33
Risk-5.5%
ATR$10.22
Simple setup: 1.5x ATR stop, 2x ATR target
Risk Metrics
Sharpe (20d)
-2.54Losing
Volatility (20d)
33.0%Normal
Beta (60d)
0.68Defensive
Alpha (20d)
-7.8%Weak
News Analysis
EN
δΈ
ν
ζ₯
No analysis record found.